21/04/2017 12:20:00

Participate in our $3 million Private Placement to Earn a Potential 20% Return on Investment in THC Therapeutics (THCT) Stock

LAS VEGAS, April 21, 2017 (GLOBE NEWSWIRE) -- THC Therapeutics (THCT) is offering a Reg D private placement to accredited investors, through which we will raise up to $3,000,000. Proceeds from this offering will start the process for THC Therapeutics to become a fully reporting company to the SEC. 50% of the money raised will go towards mergers and acquisitions, the other half will go toward general business operating expenses. This offering will be good for our company, current shareholders and new investors. An example of the terms is as follows, for a $100,000 investment in this private placement, the investor will receive $120,000 of common stock 1 year from the date of investment. The price per share will be determined by the market value at the time the common stock will be issued. This correlates to a 20% return on investment. Minimum investment is $25,000. Prior to investing, all investors must verify their accredited status. No offering is made to any person who does not meet the definition of an accredited investor under Rule 501(a). Further information is contained in our private placement memorandum, which should be reviewed in full before making a decision to invest.

Visit our website to participate in THC Therapeutics Private Placement. (http://thctherapeutics.com/)

Comments from Brandon Romanek, Founder & CEO, “Because of my vast experience as a trader, investor and portfolio manager, I have come up with a creative strategy where one can make a potential 20% return on investment. This will be great for THC Therapeutics, our current shareholders and investors in this offering. I am not willing to sell shares at a discount in an offering like this anywhere near our current stock price. Most of these types of offerings are priced below market value. Investors would have to hold for one year and this could present substantial risk to the investor. That structure does not work at all for THC Therapeutics. When a company does that, it makes a statement of what they believe their current stock price should be and that they’re willing to raise money at a significant discount to market. I am now in the process of returning 1.8 Million shares of my stock in THCT back into the company’s treasury. I am doing this to limit any dilution that can occur with this offering. I’d be happy to personally answer any questions regarding this private placement. Please call or email me directly at Brandon@thctherapeutics.com. I would like to thank everyone for believing in my vision and I promise to do whatever it takes to make THC Therapeutics a premier Health and Healing Cannabis company.”

About THC Therapeutics:

THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has "Better Health through the Science of Nature" as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics' plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.

Forward-Looking Statements Disclosure:

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

Phone: 702.602.THCC (8422)

Follow Brandon Romanek on Twitter:

Twitter @BrandonRomanek

Follow THC Therapeutics on Facebook and Twitter:

Twitter @THCTherapeutics

Facebook @THCTherapies

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
19 Apr
 
Et opgør med Finanstilsynet er tvingende nødvendigt, hvis tilliden til markedet ikke skal lægges øde..
28
08:03
OMXC25
Som tidligere påvist kan bulls køre hen over hvilken som helt bear. Hvis de altså vil. Det kræver at..
25
15 Apr
OMXC25
Virkelig intelligent indlæg. En masse om at markedet er på vej til nedtur, men sjovt nok ikke så meg..
24
18 Apr
 
LÆS NU FOR HELVEDE NOGEN AF DE 38000 indlæg som siger at børsen er nede!   Det er kraftstejleme da u..
21
19 Apr
BAVA
      Vedr. shortsqeeze mm. og den ekstreme kursmanipulation der dagligt foregår på Nasdaq Kbhvn. T..
19
20 Apr
VWS
Vestas har en ordrerbeholdning større end de nogensinde har haft, og de sendte en næsten færdigjort ..
18
18 Apr
 
Det er en katastrofe ! Hvis det fortsætter ret meget længere er vi allesammen nødt til at gå ud og l..
16
20 Apr
VWS
hvornår kommer analysen?
15
17 Apr
LAUR
An aktie man aldrig skal eje. Ejerne trækker store summer ud, at en virksomhed der kæmper for overle..
14
19 Apr
 
Hej alle,   Jeg lavede et lille indlæg på Stolt-Nielsen for nylig hvor jeg desværre – og det beklage..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Pomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers – MYGN
2
Jostens Unveils North Dakota State University Championship Rings and Fan Jewelry Collection
3
We sat down with Canadian millennial entrepreneur, Logan McLellan, to discuss the importance of using social media in modern day business
4
SYNACOR SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Synacor, Inc. - SYNC
5
Straus Family Creamery’s Sustainability Programs Signal Pioneering Organic Company’s Continued Innovation

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 April 2018 20:17:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB7 - 2018-04-21 21:17:12 - 2018-04-21 20:17:12 - 1000 - Website: OKAY